Using Whole Genome Sequencing To Hunt For A Diagnosis in Rare Disease: The Future Is Now

September 11, 2020

What was once only a futuristic vision has become reality for patients and physicians seeking answers for a rare disease. Learn how whole genome sequencing can be deployed to hunt for a diagnosis and bring new levels of understanding in ending the diagnostic odyssey. QB#10580 Subscribe to the Illumina video channel A global genomics leader, Illumina provides comprehensive next-generation sequencing solutions to the research, clinical, and applied markets. Illumina technology is responsible for generating more than 90% of the world’s sequencing data.* Through collaborative innovation, Illumina is fueling groundbreaking advancements in oncology, reproductive health, genetic disease, microbiology, agriculture, forensic science, and beyond. *Data calculations on file. Illumina, Inc., 2015. View customer spotlight videos View Illumina webinars View Illumina product videos View Illumina support videos

Share this article on